Evaluation of Abnormal Uterine Bleeding in Adolescents: A Cross Sectional Observational Study
Launched by AL-AZHAR UNIVERSITY · Jan 2, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying abnormal uterine bleeding in adolescent girls aged 10 to 19 years. Abnormal uterine bleeding can include heavy periods, irregular cycles, or bleeding between periods, and the goal of this study is to understand how common these issues are in young females and what might be causing them.
To be eligible for this study, participants must be girls aged 10 to 19 who are experiencing any type of abnormal bleeding. Girls who have normal menstrual cycles or who have never started their periods will not be included. Since the trial is not yet recruiting, there will be more information available soon about how to participate. If eligible, participants can expect to share their experiences and possibly undergo some assessments to help researchers learn more about this important issue affecting many young women.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • - Adolescent female 10- 19 years old
- • Any abnormal uterine bleeding
- Exclusion Criteria:
- • Adolescent female with normal uterine bleeding
- • Primary amenorrhea
About Al Azhar University
Al-Azhar University, a prestigious institution in Egypt, is dedicated to advancing medical research and education through rigorous clinical trials. With a strong emphasis on ethical standards and scientific integrity, the university aims to contribute to the development of innovative therapies and healthcare solutions. By fostering collaboration among researchers, healthcare professionals, and academic experts, Al-Azhar University positions itself as a leading sponsor in clinical research, committed to improving patient outcomes and enhancing the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Ahmed Ali Mohamed, professor
Study Director
Al-Azhar University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported